Data availability
Raw data from metabolomics experiments are available at https://zenodo.org under accessory number https://doi.org/10.5281/zenodo.7585114. XCMS software (http://metlin.scripps.edu/xcms/).
References
Hanaei S, Rezaei N. COVID-19: developing from an outbreak to a pandemic. Arch Med Res. 2020;51:582–4.
World Health Organization, Novel Coronavirus (2019-nCoV) Situation report-19, 25 January 2023. Geneva, Switzerland. [Internet]. [cited 2023 Jan 27]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---25-january-2023
Dong M, Qian R, Wang J, Fan J, Ye Y, Zhou H, et al. Associations of COVID-19 lockdown with gestational length and preterm birth in China. BMC Pregnancy Childbirth. 2021;27:795.
Mirzakhani K, Shoorab NJ, Akbari A, Khadivzadeh T. High-risk pregnant women’s experiences of the receiving prenatal care in COVID-19 pandemic: a qualitative study. BMC Pregnancy Childbirth. 2022;26:363.
Kadambari S, Pollard AJ, Goldacre MJ, Goldacre R. Congenital viral infections in England over five decades: a population-based observational study. Lancet Infect Dis. 2020;20:220–9.
Hantsoo L, Kornfield S, Anguera MC, Epperson CN. Inflammation: a proposed intermediary between maternal stress and offspring neuropsychiatric risk. Biol Psychiatry. 2019;85:97–106.
Zhou J, Wang Y, Zhao J, Gu L, Yang C, Wang J, et al. The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates. Eur J Clin Microbiol Infect Dis. 2021;40:565–74.
Sánchez-Luna M, Fernández Colomer B, de Alba RC, Alarcón Allen A, Baña Souto A, Camba Longueira F, et al. Neonates born to mothers with COVID-19: data from the Spanish society of neonatology registry. Pediatrics. 2021;147:e2020015065.
Holmes E, Wilson ID, Nicholson JK. Metabolic phenotyping in health and disease. Cell. 2008;5:714–7.
Nagana Gowda GA, Raftery D. Biomarker discovery and translation in metabolomics. Curr Metabolomics. 2013;1:227–40.
Doğan HO, Şenol O, Bolat S, Yıldız ŞN, Büyüktuna SA, Sarıismailoğlu R, et al. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients. J Med Virol. 2021;93:2340–9.
Li T, Ning N, Li B, Luo D, Qin E, Yu W, et al. Longitudinal metabolomics reveals ornithine cycle dysregulation correlates with inflammation and coagulation in COVID-19 severe patients. Front Microbiol. 2021;3:723818.
Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327.
Kontou A, Virgiliou C, Mouskeftara T, Begou O, Meikopoulos T, Thomaidou A, et al. Plasma lipidomic and metabolomic profiling after birth in neonates born to SARS-CoV-19 infected and non-infected mothers at delivery: preliminary results. Metabolites. 2021;30:830.
Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;17:799–805.
Carrasco I, Muñoz-Chapuli M, Vigil-Vázquez S, Aguilera-Alonso D, Hernández C, Sánchez-Sánchez C, et al. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave. BMC Pregnancy Childbirth. 2021;21:326.
Blasco H, Bessy C, Plantier L, Lefevre A, Piver E, Bernard L, et al. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci Rep. 2020;8:16824.
Gizzi AS, Grove TL, Arnold JJ, Jose J, Jangra RK, Garforth SJ, et al. A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature. 2018;1:610–4.
Mehta R, Chekmeneva E, Jackson H, Sands C, Mills E, Arancon D, et al. Antiviral metabolite 3′-deoxy-3′,4′-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19. Med. 2022;11:204–215.e6.
Deb S, Arrighi S. Potential effects of COVID-19 on cytochrome P450-mediated drug metabolism and disposition in infected patients. Eur J Drug Metab Pharmacokinet. 2021;1:185–203.
Atila A, Alay H, Yaman ME, Akman TC, Cadirci E, Bayrak B, et al. The serum amino acid profile in COVID-19. Amino Acids. 2021;53:1569–88.
Kimhofer T, Lodge S, Whiley L, Gray N, Loo RL, Lawler NG, et al. Integrative modeling of quantitative plasma lipoprotein, metabolic, and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2 infection. J Proteome Res. 2020;6:4442–54.
Lawler NG, Gray N, Kimhofer T, Boughton B, Gay M, Yang R, et al. Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J Proteome Res. 2021;7:2796–811.
Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. 2021;4:3315–29.
Das UN. Can bioactive lipids inactivate coronavirus (COVID-19)? Arch Med Res. 2020;51:282–6.
Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, et al. Cutting edge: severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome, resulting in dysregulation of eicosanoid immune mediators. J Immunol. 2021;15:329–34.
Zhang Y, Guo R, Kim SH, Shah H, Zhang S, Liang JH, et al. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat Commun. 2021;15:1676.
Acknowledgements
The authors are grateful to parents who agreed to participate in this study and the nursery staff who helped to collect the samples.
Funding
This work was supported by the Health Research Institute Carlos III (Spanish Ministry of Economy, Industry and Innovation) and co-funded by the European Union [PI18/01292, CD19/00037, CM20/00187, and CPII21/00003] and the Health Research Institute La Fe, Spain [grant number 2019-050-1_CRC].
Author information
Authors and Affiliations
Contributions
MMCV and ILC contributed equally to the study. ILC, APG, ASG, PMR, LTR, and MAG: data curation, writing–review and editing. MMCV, VRG, and GQ: formal analysis, writing–review and editing. MV, JK, and MC: conceptualization, supervision, writing–review and editing. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding authors
Ethics declarations
Conflict of interest
No financial or non-financial benefits have been received or will receive from any party related directly or indirectly to the subject of this article.
Ethical approval
The study was approved by the Ethics Committee for Biomedical Research of the Health Research Institute La Fe (Valencia, Spain) with approval number #2019-037-1 and 2020-269-1.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (MP4 49194 KB)
Rights and permissions
About this article
Cite this article
Cascant-Vilaplana, M.M., Lara-Cantón, I., Ramos-Garcia, V. et al. Metabolic dysregulation in term infants from SARS-CoV-2-infected mothers. World J Pediatr 19, 912–917 (2023). https://doi.org/10.1007/s12519-023-00735-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-023-00735-5